OSSFF (Embla Medical hf) EPS without NRI: $0.20 (TTM As of Mar. 2026)


OSSFF Embla Medical hf OSSFF
92 GF Score
Price $4.15
GF Value $5.29
! 2 Warning Signs
View Full Analysis

What is Embla Medical hf EPS without NRI?

Embla Medical hf OSSFF 92 EPS without NRI is $0.20 as of Mar. 2026. GuruFocus rates OSSFF with a GF Score™ of 92/100 and a GF Value™ of $5.29. The stock has 2 warning signs investors should review. Among 665 Medical Devices & Instruments companies, Embla Medical hf ranks better than 66.17% on this metric.

Embla Medical hf's earnings per share without non-recurring items for the three months ended in Mar. 2026 was $0.03. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was $0.20.

During the past 12 months, Embla Medical hf's average earnings per share (NRI) Growth Rate was 10.20% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 20.00% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 48.40% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 2.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Embla Medical hf's EPS without NRI or its related term are showing as below:

OSSFF' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -56.8   Med: 8.5   Max: 238.3
Current: 20

During the past 13 years, Embla Medical hf's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 238.30% per year. The lowest was -56.80% per year. And the median was 8.50% per year.

OSSFF's 3-Year EPS without NRI Growth Rate is ranked better than
66.17% of 665 companies
in the Medical Devices & Instruments industry
Industry Median: 8.1 vs OSSFF: 20.00

Embla Medical hf's EPS (Diluted) for the three months ended in Mar. 2026 was $0.03. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.20.

Embla Medical hf's EPS (Basic) for the three months ended in Mar. 2026 was $0.03. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.20.


Embla Medical hf  (OTCPK:OSSFF) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Embla Medical hf EPS without NRI Related Terms


Embla Medical hf EPS without NRI Historical Data

* Premium members only.

The historical data trend for Embla Medical hf's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Embla Medical hf EPS without NRI Chart

Embla Medical hf Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.16 0.10 0.14 0.16 0.20

Embla Medical hf Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.05 0.06 0.06 0.03

OSSFF vs ABT, SYK, MDT: EPS without NRI Comparison

For the Medical Devices subindustry, Embla Medical hf's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Embla Medical hf PE Ratio without NRI vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Embla Medical hf's PE Ratio without NRI falls into.


OSSFF
92GF Score
Embla Medical hf OSSFF
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Embla Medical hf EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $0.20 mean?
Embla Medical hf (OSSFF) has a EPS without NRI of $0.20 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Embla Medical hf and its competitors. According to the industry distribution chart, Embla Medical hf ranks #225 out of 665 companies in the Medical Devices & Instruments industry, placing it in the top 33.8%.
Is Embla Medical hf's EPS without NRI too high?
Embla Medical hf's current EPS without NRI is $0.20. The Medical Devices & Instruments industry median EPS without NRI is 8.10. Embla Medical hf's value of $0.20 is 97.5% below this industry median. Based on the distribution chart, Embla Medical hf ranks #225 out of 665 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Embla Medical hf has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Embla Medical hf's EPS without NRI compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Embla Medical hf ranks #225 out of 665 companies for EPS without NRI. This puts Embla Medical hf in the upper half of its industry. The industry median EPS without NRI is 8.10. Embla Medical hf's value of $0.20 is 97.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Devices & Instruments company?
The median EPS without NRI among Medical Devices & Instruments companies is 8.10, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Embla Medical hf's current EPS without NRI of $0.20 is 97.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Embla Medical hf and its competitors. For the Medical Devices & Instruments industry, the median EPS without NRI is 8.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Embla Medical hf's current EPS without NRI is $0.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embla Medical hf stock overvalued right now?
Embla Medical hf (OSSFF) has a current EPS without NRI of $0.20. The stock's GF Value™ is $5.29, compared to a current price of $4.15 — trading 21.6% below its estimated fair value. The current EPS without NRI is $0.20 and 97.5% below the Medical Devices & Instruments industry median of 8.10. Embla Medical hf's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Embla Medical hf (OSSFF), the current EPS without NRI is $0.20 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Embla Medical hf (OSSFF) Overvalued in 2026?

Based on GuruFocus' analysis, Embla Medical hf stock appears to be undervalued. The current stock price of $4.15 is trading 21.6% below its estimated GF Value™ of $5.29.

Key valuation signals for OSSFF:

  • EPS without NRI: $0.20
  • GF Value™: $5.29 vs. price of $4.15 (21.6% below fair value)
  • GF Score™: 92/100 with 2 warning signs
  • Industry Position: 97.5% below the Medical Devices & Instruments median (#225 of 665)

No single metric tells the full story. See the OSSFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Embla Medical hf Business Description

Address Grjothals 5, Reykjavik, ISL
Embla Medical hf operates as an orthopedic products company specializing in the design, development, manufacturing and sales of prosthetics and bracing & supports products. The company also provides patient care through a network of Orthotic and Prosthetic (O&P) facilities. It sells its products in multiple countries, with Europe and North America representing its principal markets. The company operates within three business segments: Prosthetics & Neuro Orthotics, Bracing & Supports and Patient Care. The majority of the company's revenue is derived from the Prosthetics & Neuro Orthotics, which includes products designed for users with varying mobility needs, ranging from lower-activity applications to solutions intended for more active use.
92GF Score

Get the complete analysis for OSSFF

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.15
Price
$5.29
GF Value